Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...

Black box warnings for the Ozempic include that it may increase the risk of developing thyroid tumors. The label also warns about the risk of developing stomach paralysis which can lead to nausea ...

Ozempic has skyrocketed in popularity as both a diabetes medication and a weight loss aid, but a growing number of patients are reporting an unexpected and puzzling side effect. Some users have ...

Rapid fat loss from GLP-1 medications like Ozempic can lead to 'Ozempic face', characterized by hollow cheeks and sagging skin. Drinking water, eating a protein-rich diet, and practicing face yoga ...

Novo Nordisk boasts 45 million customers using their drug Ozempic, which has caused a revolution in weight-loss treatment. Never before was there a drug that actually worked for weight loss.

Keep in mind that health insurance won’t cover Ozempic for off-label use (in this case ... Many health insurance companies, like Blue Cross Blue Shield, Aetna, United Healthcare and Cigna ...

Are you a print subscriber? Activate your account. By Ad Age Staff - 2 hours 11 min ago By Ad Age and Creativity Staff - 2 hours 28 min ago By Jack Neff - 3 hours 14 min ago 4 hours 25 min ago 6 ...

Ozempic (semaglutide) is a subcutaneous injection used in people with type 2 diabetes. It may cause mild side effects, such as abdominal pain, or more serious side effects, such as diabetic ...

The Pirates hired former MLB first baseman Daniel Vogelbach in a player development role. Read more at MLB Trade Rumors.

He also published one of the first case series that found semaglutide, the active ingredient in Ozempic, to effectively reduce alcohol consumption among six people with addiction. (The drug ...

As Ozempic and other GLP-1 drugs explode in popularity, driven by their off-label use for rapid weight ... reported seizing 369 potentially fake Ozempic pens between January and October in 2023 ...

Ozempic/Wegovy is the first drug on HHS's 2025 list of Medicare price negotiations. As the leaders of the pharmaceutical industry boarded their planes to come home from the JP Morgan Healthcare ...